| Issue Date | Title | Author(s) |
| 2023-04-01 | 3-Methoxytyrosine as an indicator of dopaminergic manipulation in equine plasma. | Keen, B; Cawley, A; Reedy, B; Noble, G; Loy, J; Fu, S |
| 2022-09 | A statistical focus on doping using a metabolomics approach | Keen, B; Cawley, A; Reedy, B; Noble, G; Fu, S |
| 2022-05 | Biomarker ratios. | Cawley, A; Keen, B; Tou, K; Elbourne, M; Keledjian, J |
| 2017-10-01 | Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes | Pasin, D; Cawley, A; Bidny, S; Fu, S |
| 2019-01-01 | Collision-induced dissociation studies of synthetic opioids for non-targeted analysis | Klingberg, J; Cawley, A; Shimmon, R; Fu, S |
| 2022-09 | Complementary biomarker detection for bisphosphonate use in racehorses | Tou, K; Cawley, A; Bishop, D; Bowen, C; Noble, G; Fu, S |
| 2017-10-01 | Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review | Pasin, D; Cawley, A; Bidny, S; Fu, S |
| 2022-04 | Developments in high-resolution mass spectrometric analyses of new psychoactive substances. | Klingberg, J; Keen, B; Cawley, A; Pasin, D; Fu, S |
| 2003-01 | Developments in sports drug testing | Trout, GJ; Rogerson, JH; Cawley, A; Alma, CW |
| 2022-07-06 | Energy-Resolved Fragmentation Aiding the Structure Elucidation of Steroid Biomarkers. | Fitzgerald, CCJ; Bowen, C; Elbourne, M; Cawley, A; McLeod, MD |
| 2020-07-05 | Finding the proverbial needle: Non-targeted screening of synthetic opioids in equine plasma. | Klingberg, J; Cawley, A; Shimmon, R; Fouracre, C; Pasin, D; Fu, S |
| 2022-05 | Intelligence benefit of the 3-methoxytyramine to tyramine ratio in equine urine. | Elbourne, M; Cawley, A; Stanley, S; Bowen, C; Fu, S |
| 2022-05 | Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry. | Tou, K; Cawley, A; Bowen, C; Sornalingam, K; Fu, S |
| 2022-09 | Metabolomic analysis of equine urine to determine route of altrenogest administration | Elbourne, M; Fu, S; Cawley, A; Bowen, C; Gupta, A |
| 2022-05 | Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues. | Keen, B; Cawley, A; Reedy, B; Fu, S |
| 2016-02-28 | The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry | Cawley, A; Pasin, D; Ganbat, N; Ennis, L; Smart, C; Greer, C; Keledjian, J; Fu, S; Chen, A |
| 2021-05 | Towards an untargeted mass spectrometric approach for improved screening in equine antidoping. | Keen, B; Cawley, A; Fouracre, C; Pyke, J; Fu, S |
| 2020-11-18 | Towards Compound Identification of Synthetic Opioids in Non-targeted Screening Using Machine Learning Techniques. | Klingberg, J; Cawley, A; Shimmon, R; Fu, S |
| 2022-12-30 | Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping. | Tou, K; Cawley, A; Bowen, C; Bishop, DP; Fu, S |
